0001104659-22-060818.txt : 20220516
0001104659-22-060818.hdr.sgml : 20220516
20220516071456
ACCESSION NUMBER: 0001104659-22-060818
CONFORMED SUBMISSION TYPE: 13F-HR/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220516
DATE AS OF CHANGE: 20220516
EFFECTIVENESS DATE: 20220516
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nextech Invest AG
CENTRAL INDEX KEY: 0001911010
IRS NUMBER: 000000000
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-22157
FILM NUMBER: 22925417
BUSINESS ADDRESS:
STREET 1: BAHNHOFSTRASSE 18
CITY: ZURICH
STATE: V8
ZIP: CH-8001
BUSINESS PHONE: 41 (0)44 366 66 11
MAIL ADDRESS:
STREET 1: BAHNHOFSTRASSE 18
CITY: ZURICH
STATE: V8
ZIP: CH-8001
13F-HR/A
1
primary_doc.xml
13F-HR/A
LIVE
false
false
false
0001911010
XXXXXXXX
12-31-2021
12-31-2021
true
1
RESTATEMENT
false
Nextech Invest AG
Bahnhofstrasse 18
Zurich
V8
CH-8001
13F HOLDINGS REPORT
028-22157
Y
This amendment is being filed solely to modify holdings of a certain security that was included in the original Form 13F filed on February 14, 2022.
Marco Weibel
Chief Financial Officer
41-44-366-66-11
/s/ Marco Weibel
Zurich
V8
05-16-2022
0
11
379574
INFORMATION TABLE
2
infotable.xml
ARVINAS INC
COM
04335A105
23595
287251
SH
SOLE
287251
0
0
C4 THERAPEUTICS INC
COM STK
12529R107
12103
375857
SH
SOLE
375857
0
0
CULLINAN ONCOLOGY INC
COM
230031106
18842
1221145
SH
SOLE
1221145
0
0
EQRX INC
COM
26886C107
89372
13104424
SH
SOLE
13104424
0
0
KINNATE BIOPHARMA INC
COM
49705R105
53306
3008243
SH
SOLE
3008243
0
0
KRONOS BIO INC
COM
50107A104
19726
1451537
SH
SOLE
1451537
0
0
PMV PHARMACEUTICALS INC
COM
69353Y103
32012
1385807
SH
SOLE
1385807
0
0
REVOLUTION MEDICINES INC
COM
76155X100
74710
2968214
SH
SOLE
2968214
0
0
SILVERBACK THERAPEUTICS INC
COM
82835W108
12721
1910029
SH
SOLE
1910029
0
0
THESEUS PHARMACEUTICALS INC
COM
88369M101
7751
611310
SH
SOLE
611310
0
0
TYRA BIOSCIENCES INC
COM
90240B106
35436
2518582
SH
SOLE
2518582
0
0